BHCM
ETON icon

Brevan Howard Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Brevan Howard Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$555K Buy
+22,506
New +$394K ﹤0.01% 1236
2025
Q2 		– Sell
-10,693
Closed -$139K – 1886
2025
Q1 		$139K Buy
+10,693
New +$162K ﹤0.01% 1027

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Brevan Howard Capital Management's ETON Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 22,506 shares worth $555K. The stake represents ﹤0.01% of the portfolio and ranks #1236 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in ETON as recently as Q1 2025.

Brevan Howard Capital Management first reported a position in ETON in Q1 2025 and has held it in 2 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Brevan Howard Capital Management held 22,506 shares of Eton Pharmaceutcials worth $555K as of Q1 2026.
  • Eton Pharmaceutcials was a new Brevan Howard Capital Management position in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1236 holding.
  • Brevan Howard Capital Management first reported a position in Eton Pharmaceutcials in Q1 2025 and has held it in 2 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.